About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 644 record(s)
Req # A-2021-000542
Adverse Drug Reaction (ADR) for RASBURICASE. Report number: 000926095.Organization: Health Canada
July 2021
Req # A-2021-000546
Adverse Reaction Reports (AERs) for METOLAZONE. Report numbers: 000925059, 000923965, 000927098.Organization: Health Canada
July 2021
Req # A-2021-000547
Adverse Drug Reaction (ADR) for CABAZITAXEL. Report number: 000926931.Organization: Health Canada
July 2021
Req # A-2021-000560
Adverse Drug Reaction (ADR) for CEFIXIME. Report number: 000921850.Organization: Health Canada
July 2021
Req # A-2021-000585
Adverse Drug Reaction (ADR) for CHOLESTYRAMINE. Report number: 000923682.Organization: Health Canada
July 2021
Req # A-2020-84
Briefing note Ref # BN0007285 Vaccine task force meetingOrganization: National Research Council Canada
July 2021
Req # A-2021-07
Briefing note Ref # BN0007285 Vaccine task force meetingOrganization: National Research Council Canada
July 2021
Req # A-2021-20
Briefing note Ref # BN20-11-65 COVID-19: Approval of Rent Relief for NRC Tenants during COVID-19Organization: National Research Council Canada
July 2021
Req # A-2021-24
Briefing note Ref # BN0007285 Vaccine task force meetingOrganization: National Research Council Canada
July 2021
Req # A-2021-27
Briefing Note Ref # BN0007793 Update on the NRC’s Clinical Trial Material FacilityOrganization: National Research Council Canada
July 2021